#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4 .
1-1	0-1	4	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Discussion
2-1	4-14	Discussion	abstract	new	_	_

#Text=Our study , conducted on a limited , though well characterized , number of young , healthy volunteers , aimed at comparing the autonomic response to cognitive and sensory tests to the best of our knowledge , and tried to fill in a significant gap in the existing literature .
3-1	15-18	Our	person|event[4]	acc|new[4]	ana|ana	3-35|3-35
3-2	19-24	study	event[4]	new[4]	_	_
3-3	25-26	,	_	_	_	_
3-4	27-36	conducted	_	_	_	_
3-5	37-39	on	_	_	_	_
3-6	40-41	a	_	_	_	_
3-7	42-49	limited	_	_	_	_
3-8	50-51	,	_	_	_	_
3-9	52-58	though	_	_	_	_
3-10	59-63	well	_	_	_	_
3-11	64-77	characterized	_	_	_	_
3-12	78-79	,	_	_	_	_
3-13	80-86	number	quantity[5]	new[5]	_	_
3-14	87-89	of	quantity[5]	new[5]	_	_
3-15	90-95	young	quantity[5]|person[6]	new[5]|new[6]	coref	20-58[166_6]
3-16	96-97	,	quantity[5]|person[6]	new[5]|new[6]	_	_
3-17	98-105	healthy	quantity[5]|person[6]	new[5]|new[6]	_	_
3-18	106-116	volunteers	quantity[5]|person[6]	new[5]|new[6]	_	_
3-19	117-118	,	_	_	_	_
3-20	119-124	aimed	_	_	_	_
3-21	125-127	at	_	_	_	_
3-22	128-137	comparing	_	_	_	_
3-23	138-141	the	abstract[7]	new[7]	coref	4-19[17_7]
3-24	142-151	autonomic	abstract[7]	new[7]	_	_
3-25	152-160	response	abstract[7]	new[7]	_	_
3-26	161-163	to	abstract[7]	new[7]	_	_
3-27	164-173	cognitive	abstract[7]|abstract[8]	new[7]|new[8]	coref	13-26[109_8]
3-28	174-177	and	abstract[7]|abstract[8]	new[7]|new[8]	_	_
3-29	178-185	sensory	abstract[7]|abstract[8]	new[7]|new[8]	_	_
3-30	186-191	tests	abstract[7]|abstract[8]	new[7]|new[8]	_	_
3-31	192-194	to	abstract[7]|abstract[8]	new[7]|new[8]	_	_
3-32	195-198	the	abstract[7]|abstract[8]	new[7]|new[8]	_	_
3-33	199-203	best	abstract[7]|abstract[8]	new[7]|new[8]	_	_
3-34	204-206	of	_	_	_	_
3-35	207-210	our	person|abstract[10]	giv|new[10]	ana|ana	5-18|5-18
3-36	211-220	knowledge	abstract[10]	new[10]	_	_
3-37	221-222	,	_	_	_	_
3-38	223-226	and	_	_	_	_
3-39	227-232	tried	_	_	_	_
3-40	233-235	to	_	_	_	_
3-41	236-240	fill	_	_	_	_
3-42	241-243	in	_	_	_	_
3-43	244-245	a	time[11]	new[11]	coref	7-15[40_11]
3-44	246-257	significant	time[11]	new[11]	_	_
3-45	258-261	gap	time[11]	new[11]	_	_
3-46	262-264	in	time[11]	new[11]	_	_
3-47	265-268	the	time[11]|abstract[12]	new[11]|new[12]	_	_
3-48	269-277	existing	time[11]|abstract[12]	new[11]|new[12]	_	_
3-49	278-288	literature	time[11]|abstract[12]	new[11]|new[12]	_	_
3-50	289-290	.	_	_	_	_

#Text=With respect to the baseline , the presentation of the six different olfactory stimuli was seen to elicit a significant response in terms of activation of the sympathetic branch of the ANS .
4-1	291-295	With	_	_	_	_
4-2	296-303	respect	abstract[13]	new[13]	coref	8-7[45_13]
4-3	304-306	to	abstract[13]	new[13]	_	_
4-4	307-310	the	abstract[13]|abstract[14]	new[13]|new[14]	_	_
4-5	311-319	baseline	abstract[13]|abstract[14]	new[13]|new[14]	_	_
4-6	320-321	,	_	_	_	_
4-7	322-325	the	abstract[15]	new[15]	_	_
4-8	326-338	presentation	abstract[15]	new[15]	_	_
4-9	339-341	of	_	_	_	_
4-10	342-345	the	abstract[16]	new[16]	_	_
4-11	346-349	six	abstract[16]	new[16]	_	_
4-12	350-359	different	abstract[16]	new[16]	_	_
4-13	360-369	olfactory	abstract[16]	new[16]	_	_
4-14	370-377	stimuli	abstract[16]	new[16]	_	_
4-15	378-381	was	_	_	_	_
4-16	382-386	seen	_	_	_	_
4-17	387-389	to	_	_	_	_
4-18	390-396	elicit	_	_	_	_
4-19	397-398	a	abstract[17]	giv[17]	coref	11-16[93_17]
4-20	399-410	significant	abstract[17]	giv[17]	_	_
4-21	411-419	response	abstract[17]	giv[17]	_	_
4-22	420-422	in	abstract[17]	giv[17]	_	_
4-23	423-428	terms	abstract[17]	giv[17]	_	_
4-24	429-431	of	abstract[17]	giv[17]	_	_
4-25	432-442	activation	abstract[17]|abstract[18]	giv[17]|new[18]	coref	10-42[87_18]
4-26	443-445	of	abstract[17]|abstract[18]	giv[17]|new[18]	_	_
4-27	446-449	the	abstract[17]|abstract[18]|abstract[19]	giv[17]|new[18]|new[19]	_	_
4-28	450-461	sympathetic	abstract[17]|abstract[18]|abstract[19]	giv[17]|new[18]|new[19]	_	_
4-29	462-468	branch	abstract[17]|abstract[18]|abstract[19]	giv[17]|new[18]|new[19]	_	_
4-30	469-471	of	abstract[17]|abstract[18]|abstract[19]	giv[17]|new[18]|new[19]	_	_
4-31	472-475	the	abstract[17]|abstract[18]|abstract[19]|place[20]	giv[17]|new[18]|new[19]|new[20]	coref	8-15[0_20]
4-32	476-479	ANS	abstract[17]|abstract[18]|abstract[19]|place[20]	giv[17]|new[18]|new[19]|new[20]	_	_
4-33	480-481	.	_	_	_	_

#Text=Having reported that the olfactory compounds used included odors normally judged as both pleasant and unpleasant , our findings are somewhat similar to the retrievals of Bensafi et al. , limited to unpleasant odors .
5-1	482-488	Having	_	_	_	_
5-2	489-497	reported	_	_	_	_
5-3	498-502	that	_	_	_	_
5-4	503-506	the	object[21]	new[21]	_	_
5-5	507-516	olfactory	object[21]	new[21]	_	_
5-6	517-526	compounds	object[21]	new[21]	_	_
5-7	527-531	used	_	_	_	_
5-8	532-540	included	_	_	_	_
5-9	541-546	odors	abstract	new	coref	5-33[27_0]
5-10	547-555	normally	_	_	_	_
5-11	556-562	judged	_	_	_	_
5-12	563-565	as	_	_	_	_
5-13	566-570	both	_	_	_	_
5-14	571-579	pleasant	_	_	_	_
5-15	580-583	and	_	_	_	_
5-16	584-594	unpleasant	_	_	_	_
5-17	595-596	,	_	_	_	_
5-18	597-600	our	person|abstract[24]	giv|new[24]	ana|coref|ana|coref	6-4|9-30[71_24]|6-4|9-30[71_24]
5-19	601-609	findings	abstract[24]	new[24]	_	_
5-20	610-613	are	_	_	_	_
5-21	614-622	somewhat	_	_	_	_
5-22	623-630	similar	_	_	_	_
5-23	631-633	to	_	_	_	_
5-24	634-637	the	abstract[25]	new[25]	_	_
5-25	638-648	retrievals	abstract[25]	new[25]	_	_
5-26	649-651	of	abstract[25]	new[25]	_	_
5-27	652-659	Bensafi	abstract[25]|person	new[25]|new	_	_
5-28	660-662	et	abstract[25]	new[25]	_	_
5-29	663-666	al.	abstract[25]	new[25]	_	_
5-30	667-668	,	abstract[25]	new[25]	_	_
5-31	669-676	limited	abstract[25]	new[25]	_	_
5-32	677-679	to	_	_	_	_
5-33	680-690	unpleasant	abstract[27]	giv[27]	coref	6-23[0_27]
5-34	691-696	odors	abstract[27]	giv[27]	_	_
5-35	697-698	.	_	_	_	_

#Text=In addition , we also failed to find significant correlations between autonomic parameters and odor pleasantness , confirming that pleasant versus unpleasant odors do not cause significantly different autonomic responses in healthy subjects .
6-1	699-701	In	_	_	_	_
6-2	702-710	addition	_	_	_	_
6-3	711-712	,	_	_	_	_
6-4	713-715	we	person	giv	ana	9-30
6-5	716-720	also	_	_	_	_
6-6	721-727	failed	_	_	_	_
6-7	728-730	to	_	_	_	_
6-8	731-735	find	_	_	_	_
6-9	736-747	significant	abstract[29]	new[29]	coref	23-12[191_29]
6-10	748-760	correlations	abstract[29]	new[29]	_	_
6-11	761-768	between	abstract[29]	new[29]	_	_
6-12	769-778	autonomic	abstract[29]|abstract[30]	new[29]|new[30]	coref	23-24[195_30]
6-13	779-789	parameters	abstract[29]|abstract[30]	new[29]|new[30]	_	_
6-14	790-793	and	abstract[29]	new[29]	_	_
6-15	794-798	odor	abstract[29]|abstract|abstract[32]	new[29]|new|new[32]	_	_
6-16	799-811	pleasantness	abstract[29]|abstract[32]	new[29]|new[32]	_	_
6-17	812-813	,	_	_	_	_
6-18	814-824	confirming	_	_	_	_
6-19	825-829	that	_	_	_	_
6-20	830-838	pleasant	_	_	_	_
6-21	839-845	versus	_	_	_	_
6-22	846-856	unpleasant	_	_	_	_
6-23	857-862	odors	abstract	giv	_	_
6-24	863-865	do	_	_	_	_
6-25	866-869	not	_	_	_	_
6-26	870-875	cause	_	_	_	_
6-27	876-889	significantly	abstract[34]	new[34]	coref	10-4[74_34]
6-28	890-899	different	abstract[34]	new[34]	_	_
6-29	900-909	autonomic	abstract[34]	new[34]	_	_
6-30	910-919	responses	abstract[34]	new[34]	_	_
6-31	920-922	in	abstract[34]	new[34]	_	_
6-32	923-930	healthy	abstract[34]|abstract[35]	new[34]|new[35]	coref	13-22[107_35]
6-33	931-939	subjects	abstract[34]|abstract[35]	new[34]|new[35]	_	_
6-34	940-941	.	_	_	_	_

#Text=After the olfactory stimulation , the TSST further increased the SNS activity , at the same time highlighting a somewhat parasympathetic withdrawal , as demonstrated by the simultaneous decrease of both SDNN and pNN50 .
7-1	942-947	After	_	_	_	_
7-2	948-951	the	abstract[36]	new[36]	coref	10-7[75_36]
7-3	952-961	olfactory	abstract[36]	new[36]	_	_
7-4	962-973	stimulation	abstract[36]	new[36]	_	_
7-5	974-975	,	_	_	_	_
7-6	976-979	the	abstract[37]	new[37]	coref	8-9[46_37]
7-7	980-984	TSST	abstract[37]	new[37]	_	_
7-8	985-992	further	_	_	_	_
7-9	993-1002	increased	_	_	_	_
7-10	1003-1006	the	abstract[39]	new[39]	coref	14-29[124_39]
7-11	1007-1010	SNS	abstract|abstract[39]	new|new[39]	coref	10-43
7-12	1011-1019	activity	abstract[39]	new[39]	_	_
7-13	1020-1021	,	_	_	_	_
7-14	1022-1024	at	_	_	_	_
7-15	1025-1028	the	time[40]	giv[40]	_	_
7-16	1029-1033	same	time[40]	giv[40]	_	_
7-17	1034-1038	time	time[40]	giv[40]	_	_
7-18	1039-1051	highlighting	_	_	_	_
7-19	1052-1053	a	abstract[41]	new[41]	coref	14-16[118_41]
7-20	1054-1062	somewhat	abstract[41]	new[41]	_	_
7-21	1063-1078	parasympathetic	abstract[41]	new[41]	_	_
7-22	1079-1089	withdrawal	abstract[41]	new[41]	_	_
7-23	1090-1091	,	_	_	_	_
7-24	1092-1094	as	_	_	_	_
7-25	1095-1107	demonstrated	_	_	_	_
7-26	1108-1110	by	_	_	_	_
7-27	1111-1114	the	abstract[42]	new[42]	_	_
7-28	1115-1127	simultaneous	abstract[42]	new[42]	_	_
7-29	1128-1136	decrease	abstract[42]	new[42]	_	_
7-30	1137-1139	of	abstract[42]	new[42]	_	_
7-31	1140-1144	both	abstract[42]|abstract[43]	new[42]|new[43]	_	_
7-32	1145-1149	SDNN	abstract[42]|abstract[43]	new[42]|new[43]	_	_
7-33	1150-1153	and	abstract[42]	new[42]	_	_
7-34	1154-1159	pNN50	abstract[42]|quantity	new[42]|new	_	_
7-35	1160-1161	.	_	_	_	_

#Text=Despite not being extensively studied with respect to the TSST , this kind of ANS behavior is consistent with the results by Boesch et al. , which , with a slightly different protocol , found an increase in HR together with a contextual decrease of HRV features during the administration of the TSST for groups ( TSST-G ) .
8-1	1162-1169	Despite	_	_	_	_
8-2	1170-1173	not	_	_	_	_
8-3	1174-1179	being	_	_	_	_
8-4	1180-1191	extensively	_	_	_	_
8-5	1192-1199	studied	_	_	_	_
8-6	1200-1204	with	_	_	_	_
8-7	1205-1212	respect	abstract[45]	giv[45]	_	_
8-8	1213-1215	to	abstract[45]	giv[45]	_	_
8-9	1216-1219	the	abstract[45]|abstract[46]	giv[45]|giv[46]	coref	8-52[58_46]
8-10	1220-1224	TSST	abstract[45]|abstract[46]	giv[45]|giv[46]	_	_
8-11	1225-1226	,	_	_	_	_
8-12	1227-1231	this	_	_	_	_
8-13	1232-1236	kind	abstract[48]	new[48]	coref	16-23[137_48]
8-14	1237-1239	of	abstract[48]	new[48]	_	_
8-15	1240-1243	ANS	place|abstract[48]	giv|new[48]	coref	10-4
8-16	1244-1252	behavior	abstract[48]	new[48]	_	_
8-17	1253-1255	is	_	_	_	_
8-18	1256-1266	consistent	_	_	_	_
8-19	1267-1271	with	_	_	_	_
8-20	1272-1275	the	abstract[49]	new[49]	coref	9-1[61_49]
8-21	1276-1283	results	abstract[49]	new[49]	_	_
8-22	1284-1286	by	abstract[49]	new[49]	_	_
8-23	1287-1293	Boesch	abstract[49]|person	new[49]|new	_	_
8-24	1294-1296	et	abstract[49]	new[49]	_	_
8-25	1297-1300	al.	abstract[49]	new[49]	_	_
8-26	1301-1302	,	_	_	_	_
8-27	1303-1308	which	_	_	_	_
8-28	1309-1310	,	_	_	_	_
8-29	1311-1315	with	_	_	_	_
8-30	1316-1317	a	abstract[51]	new[51]	coref	10-11[77_51]
8-31	1318-1326	slightly	abstract[51]	new[51]	_	_
8-32	1327-1336	different	abstract[51]	new[51]	_	_
8-33	1337-1345	protocol	abstract[51]	new[51]	_	_
8-34	1346-1347	,	_	_	_	_
8-35	1348-1353	found	_	_	_	_
8-36	1354-1356	an	abstract[52]	new[52]	_	_
8-37	1357-1365	increase	abstract[52]	new[52]	_	_
8-38	1366-1368	in	abstract[52]	new[52]	_	_
8-39	1369-1371	HR	abstract[52]|time	new[52]|new	coref	9-6
8-40	1372-1380	together	_	_	_	_
8-41	1381-1385	with	_	_	_	_
8-42	1386-1387	a	event[54]	new[54]	_	_
8-43	1388-1398	contextual	event[54]	new[54]	_	_
8-44	1399-1407	decrease	event[54]	new[54]	_	_
8-45	1408-1410	of	event[54]	new[54]	_	_
8-46	1411-1414	HRV	event[54]|abstract|abstract[56]	new[54]|new|new[56]	coref|coref|coref|coref	9-9|27-12[211_56]|9-9|27-12[211_56]
8-47	1415-1423	features	event[54]|abstract[56]	new[54]|new[56]	_	_
8-48	1424-1430	during	event[54]|abstract[56]	new[54]|new[56]	_	_
8-49	1431-1434	the	event[54]|abstract[56]|event[57]	new[54]|new[56]|new[57]	_	_
8-50	1435-1449	administration	event[54]|abstract[56]|event[57]	new[54]|new[56]|new[57]	_	_
8-51	1450-1452	of	event[54]|abstract[56]|event[57]	new[54]|new[56]|new[57]	_	_
8-52	1453-1456	the	event[54]|abstract[56]|event[57]|abstract[58]	new[54]|new[56]|new[57]|giv[58]	coref	9-12[0_58]
8-53	1457-1461	TSST	event[54]|abstract[56]|event[57]|abstract[58]	new[54]|new[56]|new[57]|giv[58]	_	_
8-54	1462-1465	for	event[54]|abstract[56]|event[57]|abstract[58]	new[54]|new[56]|new[57]|giv[58]	_	_
8-55	1466-1472	groups	event[54]|abstract[56]|event[57]|abstract[58]|person	new[54]|new[56]|new[57]|giv[58]|new	_	_
8-56	1473-1474	(	_	_	_	_
8-57	1475-1481	TSST-G	abstract	new	_	_
8-58	1482-1483	)	_	_	_	_
8-59	1484-1485	.	_	_	_	_

#Text=Similar results in terms of HR augmentation and HRV reduction under TSST stress were also found in several other protocols ( see ) , strengthening the scientific value of our findings .
9-1	1486-1493	Similar	abstract[61]	giv[61]	coref	27-3[209_61]
9-2	1494-1501	results	abstract[61]	giv[61]	_	_
9-3	1502-1504	in	abstract[61]	giv[61]	_	_
9-4	1505-1510	terms	abstract[61]	giv[61]	_	_
9-5	1511-1513	of	abstract[61]	giv[61]	_	_
9-6	1514-1516	HR	abstract[61]|time|abstract[63]	giv[61]|giv|new[63]	_	_
9-7	1517-1529	augmentation	abstract[61]|abstract[63]	giv[61]|new[63]	_	_
9-8	1530-1533	and	abstract[61]	giv[61]	_	_
9-9	1534-1537	HRV	abstract[61]|abstract|abstract[65]	giv[61]|giv|new[65]	_	_
9-10	1538-1547	reduction	abstract[61]|abstract[65]	giv[61]|new[65]	_	_
9-11	1548-1553	under	abstract[61]|abstract[65]	giv[61]|new[65]	_	_
9-12	1554-1558	TSST	abstract[61]|abstract[65]|abstract|abstract[67]	giv[61]|new[65]|giv|new[67]	coref|coref|coref|coref	10-12|11-11[0_67]|10-12|11-11[0_67]
9-13	1559-1565	stress	abstract[61]|abstract[65]|abstract[67]	giv[61]|new[65]|new[67]	_	_
9-14	1566-1570	were	_	_	_	_
9-15	1571-1575	also	_	_	_	_
9-16	1576-1581	found	_	_	_	_
9-17	1582-1584	in	_	_	_	_
9-18	1585-1592	several	abstract[68]	new[68]	coref	23-1[189_68]
9-19	1593-1598	other	abstract[68]	new[68]	_	_
9-20	1599-1608	protocols	abstract[68]	new[68]	_	_
9-21	1609-1610	(	_	_	_	_
9-22	1611-1614	see	_	_	_	_
9-23	1615-1616	)	_	_	_	_
9-24	1617-1618	,	_	_	_	_
9-25	1619-1632	strengthening	_	_	_	_
9-26	1633-1636	the	abstract[69]	new[69]	_	_
9-27	1637-1647	scientific	abstract[69]	new[69]	_	_
9-28	1648-1653	value	abstract[69]	new[69]	_	_
9-29	1654-1656	of	abstract[69]	new[69]	_	_
9-30	1657-1660	our	abstract[69]|person|abstract[71]	new[69]|giv|giv[71]	coref|ana|coref|ana	18-1[140_71]|21-18|18-1[140_71]|21-18
9-31	1661-1669	findings	abstract[69]|abstract[71]	new[69]|giv[71]	_	_
9-32	1670-1671	.	_	_	_	_

#Text=The comparison between ANS responses to olfactory stimulation and to the TSST protocol made it possible to compare Task I and Task II , as well as Task II and Task III responses , and highlighted a much higher contribution to the SNS activation borne by the TSST .
10-1	1672-1675	The	abstract[72]	new[72]	_	_
10-2	1676-1686	comparison	abstract[72]	new[72]	_	_
10-3	1687-1694	between	abstract[72]	new[72]	_	_
10-4	1695-1698	ANS	abstract[72]|place|abstract[74]	new[72]|giv|giv[74]	coref|coref|coref|coref	10-32[84_74]|12-8|10-32[84_74]|12-8
10-5	1699-1708	responses	abstract[72]|abstract[74]	new[72]|giv[74]	_	_
10-6	1709-1711	to	abstract[72]|abstract[74]	new[72]|giv[74]	_	_
10-7	1712-1721	olfactory	abstract[72]|abstract[74]|abstract[75]	new[72]|giv[74]|giv[75]	coref	12-4[96_75]
10-8	1722-1733	stimulation	abstract[72]|abstract[74]|abstract[75]	new[72]|giv[74]|giv[75]	_	_
10-9	1734-1737	and	abstract[72]|abstract[74]	new[72]|giv[74]	_	_
10-10	1738-1740	to	abstract[72]|abstract[74]	new[72]|giv[74]	_	_
10-11	1741-1744	the	abstract[72]|abstract[74]|abstract[77]	new[72]|giv[74]|giv[77]	ana	10-15[0_77]
10-12	1745-1749	TSST	abstract[72]|abstract[74]|abstract|abstract[77]	new[72]|giv[74]|giv|giv[77]	coref	10-47[88_0]
10-13	1750-1758	protocol	abstract[72]|abstract[74]|abstract[77]	new[72]|giv[74]|giv[77]	_	_
10-14	1759-1763	made	_	_	_	_
10-15	1764-1766	it	abstract	giv	coref	14-21[121_0]
10-16	1767-1775	possible	_	_	_	_
10-17	1776-1778	to	_	_	_	_
10-18	1779-1786	compare	_	_	_	_
10-19	1787-1791	Task	abstract|abstract[80]	new|new[80]	coref|coref|coref|coref	10-22[82_0]|14-11[115_80]|10-22[82_0]|14-11[115_80]
10-20	1792-1793	I	abstract[80]|person	new[80]|acc	_	_
10-21	1794-1797	and	abstract[80]	new[80]	_	_
10-22	1798-1802	Task	abstract[80]|abstract[82]	new[80]|giv[82]	coref	10-28[83_82]
10-23	1803-1805	II	abstract[80]|abstract[82]	new[80]|giv[82]	_	_
10-24	1806-1807	,	abstract[80]	new[80]	_	_
10-25	1808-1810	as	abstract[80]	new[80]	_	_
10-26	1811-1815	well	abstract[80]	new[80]	_	_
10-27	1816-1818	as	abstract[80]	new[80]	_	_
10-28	1819-1823	Task	abstract[80]|abstract[83]	new[80]|giv[83]	coref	11-8[91_83]
10-29	1824-1826	II	abstract[80]|abstract[83]	new[80]|giv[83]	_	_
10-30	1827-1830	and	abstract[80]|abstract[83]	new[80]|giv[83]	_	_
10-31	1831-1835	Task	abstract[80]|abstract[83]	new[80]|giv[83]	_	_
10-32	1836-1839	III	abstract[80]|abstract[83]|abstract[84]	new[80]|giv[83]|giv[84]	_	_
10-33	1840-1849	responses	abstract[80]|abstract[83]|abstract[84]	new[80]|giv[83]|giv[84]	_	_
10-34	1850-1851	,	abstract[80]	new[80]	_	_
10-35	1852-1855	and	abstract[80]	new[80]	_	_
10-36	1856-1867	highlighted	abstract[80]	new[80]	_	_
10-37	1868-1869	a	abstract[80]|abstract[85]	new[80]|new[85]	_	_
10-38	1870-1874	much	abstract[80]|abstract[85]	new[80]|new[85]	_	_
10-39	1875-1881	higher	abstract[80]|abstract[85]	new[80]|new[85]	_	_
10-40	1882-1894	contribution	abstract[80]|abstract[85]	new[80]|new[85]	_	_
10-41	1895-1897	to	abstract[80]|abstract[85]	new[80]|new[85]	_	_
10-42	1898-1901	the	abstract[80]|abstract[85]|abstract[87]	new[80]|new[85]|giv[87]	coref	12-8[98_87]
10-43	1902-1905	SNS	abstract[80]|abstract[85]|abstract|abstract[87]	new[80]|new[85]|giv|giv[87]	_	_
10-44	1906-1916	activation	abstract[80]|abstract[85]|abstract[87]	new[80]|new[85]|giv[87]	_	_
10-45	1917-1922	borne	_	_	_	_
10-46	1923-1925	by	_	_	_	_
10-47	1926-1929	the	abstract[88]	giv[88]	coref	11-3[0_88]
10-48	1930-1934	TSST	abstract[88]	giv[88]	_	_
10-49	1935-1936	.	_	_	_	_

#Text=Therefore , TSST was confirmed to represent a powerful psychosocial stress task capable to induce an acute stress response of all main physiologic stress systems .
11-1	1937-1946	Therefore	_	_	_	_
11-2	1947-1948	,	_	_	_	_
11-3	1949-1953	TSST	abstract	giv	coref	13-13
11-4	1954-1957	was	_	_	_	_
11-5	1958-1967	confirmed	_	_	_	_
11-6	1968-1970	to	_	_	_	_
11-7	1971-1980	represent	_	_	_	_
11-8	1981-1982	a	abstract[91]	giv[91]	coref	14-11[114_91]
11-9	1983-1991	powerful	abstract[91]	giv[91]	_	_
11-10	1992-2004	psychosocial	abstract[91]	giv[91]	_	_
11-11	2005-2011	stress	abstract|abstract[91]	giv|giv[91]	coref	11-18
11-12	2012-2016	task	abstract[91]	giv[91]	_	_
11-13	2017-2024	capable	abstract[91]	giv[91]	_	_
11-14	2025-2027	to	abstract[91]	giv[91]	_	_
11-15	2028-2034	induce	abstract[91]	giv[91]	_	_
11-16	2035-2037	an	abstract[91]|abstract[93]	giv[91]|giv[93]	coref	13-4[101_93]
11-17	2038-2043	acute	abstract[91]|abstract[93]	giv[91]|giv[93]	_	_
11-18	2044-2050	stress	abstract[91]|abstract|abstract[93]	giv[91]|giv|giv[93]	coref	11-24
11-19	2051-2059	response	abstract[91]|abstract[93]	giv[91]|giv[93]	_	_
11-20	2060-2062	of	abstract[91]|abstract[93]	giv[91]|giv[93]	_	_
11-21	2063-2066	all	abstract[91]|abstract[93]|abstract[95]	giv[91]|giv[93]|new[95]	_	_
11-22	2067-2071	main	abstract[91]|abstract[93]|abstract[95]	giv[91]|giv[93]|new[95]	_	_
11-23	2072-2083	physiologic	abstract[91]|abstract[93]|abstract[95]	giv[91]|giv[93]|new[95]	_	_
11-24	2084-2090	stress	abstract[91]|abstract[93]|abstract|abstract[95]	giv[91]|giv[93]|giv|new[95]	coref	13-19
11-25	2091-2098	systems	abstract[91]|abstract[93]|abstract[95]	giv[91]|giv[93]|new[95]	_	_
11-26	2099-2100	.	_	_	_	_

#Text=In addition , olfactory stimulation also elicited ANS activation ( particularly SNS )
12-1	2101-2103	In	_	_	_	_
12-2	2104-2112	addition	_	_	_	_
12-3	2113-2114	,	_	_	_	_
12-4	2115-2124	olfactory	abstract[96]	giv[96]	coref	25-20[205_96]
12-5	2125-2136	stimulation	abstract[96]	giv[96]	_	_
12-6	2137-2141	also	_	_	_	_
12-7	2142-2150	elicited	_	_	_	_
12-8	2151-2154	ANS	place|abstract[98]	giv|giv[98]	appos|coref|appos|coref	12-11[99_98]|14-18|12-11[99_98]|14-18
12-9	2155-2165	activation	abstract[98]	giv[98]	_	_
12-10	2166-2167	(	_	_	_	_
12-11	2168-2180	particularly	abstract[99]	giv[99]	coref	14-29[122_99]
12-12	2181-2184	SNS	abstract[99]	giv[99]	_	_
12-13	2185-2186	)	_	_	_	_

#Text=The magnitude of this response was significantly smaller than that occurring with TSST , highlighting its usefulness in stress monitoring of subjects unable to undergo complex mathematical stress tests , limited to some particularly controlled experimental settings .
13-1	2187-2190	The	abstract[100]	new[100]	_	_
13-2	2191-2200	magnitude	abstract[100]	new[100]	_	_
13-3	2201-2203	of	abstract[100]	new[100]	_	_
13-4	2204-2208	this	abstract[100]|abstract[101]	new[100]|giv[101]	coref	29-25[239_101]
13-5	2209-2217	response	abstract[100]|abstract[101]	new[100]|giv[101]	_	_
13-6	2218-2221	was	_	_	_	_
13-7	2222-2235	significantly	_	_	_	_
13-8	2236-2243	smaller	_	_	_	_
13-9	2244-2248	than	_	_	_	_
13-10	2249-2253	that	_	_	_	_
13-11	2254-2263	occurring	_	_	_	_
13-12	2264-2268	with	_	_	_	_
13-13	2269-2273	TSST	abstract	giv	ana	13-16
13-14	2274-2275	,	_	_	_	_
13-15	2276-2288	highlighting	_	_	_	_
13-16	2289-2292	its	abstract|abstract[104]	giv|new[104]	coref|coref	15-15|15-15
13-17	2293-2303	usefulness	abstract[104]	new[104]	_	_
13-18	2304-2306	in	abstract[104]	new[104]	_	_
13-19	2307-2313	stress	abstract[104]|abstract|event[106]	new[104]|giv|new[106]	coref|coref	13-28|13-28
13-20	2314-2324	monitoring	abstract[104]|event[106]	new[104]|new[106]	_	_
13-21	2325-2327	of	abstract[104]|event[106]	new[104]|new[106]	_	_
13-22	2328-2336	subjects	abstract[104]|event[106]|abstract[107]	new[104]|new[106]|giv[107]	coref	15-9[0_107]
13-23	2337-2343	unable	abstract[104]|event[106]|abstract[107]	new[104]|new[106]|giv[107]	_	_
13-24	2344-2346	to	abstract[104]|event[106]|abstract[107]	new[104]|new[106]|giv[107]	_	_
13-25	2347-2354	undergo	abstract[104]|event[106]|abstract[107]	new[104]|new[106]|giv[107]	_	_
13-26	2355-2362	complex	abstract[104]|event[106]|abstract[107]|abstract[109]	new[104]|new[106]|giv[107]|giv[109]	_	_
13-27	2363-2375	mathematical	abstract[104]|event[106]|abstract[107]|abstract[109]	new[104]|new[106]|giv[107]|giv[109]	_	_
13-28	2376-2382	stress	abstract[104]|event[106]|abstract[107]|abstract|abstract[109]	new[104]|new[106]|giv[107]|giv|giv[109]	coref	14-24
13-29	2383-2388	tests	abstract[104]|event[106]|abstract[107]|abstract[109]	new[104]|new[106]|giv[107]|giv[109]	_	_
13-30	2389-2390	,	_	_	_	_
13-31	2391-2398	limited	_	_	_	_
13-32	2399-2401	to	_	_	_	_
13-33	2402-2406	some	abstract[110]	new[110]	_	_
13-34	2407-2419	particularly	abstract[110]	new[110]	_	_
13-35	2420-2430	controlled	abstract[110]	new[110]	_	_
13-36	2431-2443	experimental	abstract[110]	new[110]	_	_
13-37	2444-2452	settings	abstract[110]	new[110]	_	_
13-38	2453-2454	.	_	_	_	_

#Text=Interestingly , the trends noticed in the phase transition between Task III and recovery suggest an overall ANS withdrawal after a massive psycho-sensory stress protocol , being that both SNS and PNS activity decreased at this stage .
14-1	2455-2468	Interestingly	_	_	_	_
14-2	2469-2470	,	_	_	_	_
14-3	2471-2474	the	abstract[111]	new[111]	_	_
14-4	2475-2481	trends	abstract[111]	new[111]	_	_
14-5	2482-2489	noticed	_	_	_	_
14-6	2490-2492	in	_	_	_	_
14-7	2493-2496	the	event[113]	new[113]	_	_
14-8	2497-2502	phase	abstract|event[113]	new|new[113]	coref	14-36[125_0]
14-9	2503-2513	transition	event[113]	new[113]	_	_
14-10	2514-2521	between	event[113]	new[113]	_	_
14-11	2522-2526	Task	event[113]|abstract[114]|abstract[115]	new[113]|giv[114]|giv[115]	_	_
14-12	2527-2530	III	event[113]|abstract[114]|abstract[115]	new[113]|giv[114]|giv[115]	_	_
14-13	2531-2534	and	event[113]|abstract[115]	new[113]|giv[115]	_	_
14-14	2535-2543	recovery	event[113]|abstract[115]|event	new[113]|giv[115]|new	coref	24-14
14-15	2544-2551	suggest	_	_	_	_
14-16	2552-2554	an	abstract[118]	giv[118]	_	_
14-17	2555-2562	overall	abstract[118]	giv[118]	_	_
14-18	2563-2566	ANS	place|abstract[118]	giv|giv[118]	coref	21-23
14-19	2567-2577	withdrawal	abstract[118]	giv[118]	_	_
14-20	2578-2583	after	abstract[118]	giv[118]	_	_
14-21	2584-2585	a	abstract[118]|abstract[121]	giv[118]|giv[121]	coref	15-14[129_121]
14-22	2586-2593	massive	abstract[118]|abstract[121]	giv[118]|giv[121]	_	_
14-23	2594-2608	psycho-sensory	abstract[118]|abstract|abstract[121]	giv[118]|new|giv[121]	_	_
14-24	2609-2615	stress	abstract[118]|abstract|abstract[121]	giv[118]|giv|giv[121]	coref	21-34
14-25	2616-2624	protocol	abstract[118]|abstract[121]	giv[118]|giv[121]	_	_
14-26	2625-2626	,	abstract[118]	giv[118]	_	_
14-27	2627-2632	being	abstract[118]	giv[118]	_	_
14-28	2633-2637	that	abstract[118]	giv[118]	_	_
14-29	2638-2642	both	abstract[118]|abstract[122]|abstract[124]	giv[118]|giv[122]|giv[124]	coref|coref	15-18[131_122]|15-18[131_122]
14-30	2643-2646	SNS	abstract[118]|abstract[122]|abstract[124]	giv[118]|giv[122]|giv[124]	_	_
14-31	2647-2650	and	abstract[118]|abstract[124]	giv[118]|giv[124]	_	_
14-32	2651-2654	PNS	abstract[118]|place|abstract[124]	giv[118]|new|giv[124]	coref	15-19
14-33	2655-2663	activity	abstract[118]|abstract[124]	giv[118]|giv[124]	_	_
14-34	2664-2673	decreased	_	_	_	_
14-35	2674-2676	at	_	_	_	_
14-36	2677-2681	this	abstract[125]	giv[125]	coref	15-22[132_125]
14-37	2682-2687	stage	abstract[125]	giv[125]	_	_
14-38	2688-2689	.	_	_	_	_

#Text=Finally , the only significant correlation revealed that subjects who more quickly completing the TSST protocol displayed higher PNS activation in the following phase .
15-1	2690-2697	Finally	_	_	_	_
15-2	2698-2699	,	_	_	_	_
15-3	2700-2703	the	abstract[126]	new[126]	_	_
15-4	2704-2708	only	abstract[126]	new[126]	_	_
15-5	2709-2720	significant	abstract[126]	new[126]	_	_
15-6	2721-2732	correlation	abstract[126]	new[126]	_	_
15-7	2733-2741	revealed	_	_	_	_
15-8	2742-2746	that	_	_	_	_
15-9	2747-2755	subjects	abstract	giv	coref	20-25[155_0]
15-10	2756-2759	who	_	_	_	_
15-11	2760-2764	more	_	_	_	_
15-12	2765-2772	quickly	_	_	_	_
15-13	2773-2783	completing	_	_	_	_
15-14	2784-2787	the	abstract[129]	giv[129]	coref	21-13[169_129]
15-15	2788-2792	TSST	abstract|abstract[129]	giv|giv[129]	_	_
15-16	2793-2801	protocol	abstract[129]	giv[129]	_	_
15-17	2802-2811	displayed	_	_	_	_
15-18	2812-2818	higher	abstract[131]	giv[131]	_	_
15-19	2819-2822	PNS	place|abstract[131]	giv|giv[131]	coref	16-12[135_0]
15-20	2823-2833	activation	abstract[131]	giv[131]	_	_
15-21	2834-2836	in	_	_	_	_
15-22	2837-2840	the	abstract[132]	giv[132]	coref	24-13[199_132]
15-23	2841-2850	following	abstract[132]	giv[132]	_	_
15-24	2851-2856	phase	abstract[132]	giv[132]	_	_
15-25	2857-2858	.	_	_	_	_

#Text=This result could be speculated in terms of sustained hyper-reactivity of the PNS , as a marker of increased selective attention and higher-order behavior and cognition ( e. g. , see ) .
16-1	2859-2863	This	abstract[133]	new[133]	_	_
16-2	2864-2870	result	abstract[133]	new[133]	_	_
16-3	2871-2876	could	_	_	_	_
16-4	2877-2879	be	_	_	_	_
16-5	2880-2890	speculated	_	_	_	_
16-6	2891-2893	in	_	_	_	_
16-7	2894-2899	terms	_	_	_	_
16-8	2900-2902	of	_	_	_	_
16-9	2903-2912	sustained	abstract[134]	new[134]	_	_
16-10	2913-2929	hyper-reactivity	abstract[134]	new[134]	_	_
16-11	2930-2932	of	abstract[134]	new[134]	_	_
16-12	2933-2936	the	abstract[134]|place[135]	new[134]|giv[135]	_	_
16-13	2937-2940	PNS	abstract[134]|place[135]	new[134]|giv[135]	_	_
16-14	2941-2942	,	_	_	_	_
16-15	2943-2945	as	_	_	_	_
16-16	2946-2947	a	_	_	_	_
16-17	2948-2954	marker	_	_	_	_
16-18	2955-2957	of	_	_	_	_
16-19	2958-2967	increased	abstract[136]	new[136]	_	_
16-20	2968-2977	selective	abstract[136]	new[136]	_	_
16-21	2978-2987	attention	abstract[136]	new[136]	_	_
16-22	2988-2991	and	_	_	_	_
16-23	2992-3004	higher-order	abstract[137]	giv[137]	_	_
16-24	3005-3013	behavior	abstract[137]	giv[137]	_	_
16-25	3014-3017	and	_	_	_	_
16-26	3018-3027	cognition	abstract	new	_	_
16-27	3028-3029	(	_	_	_	_
16-28	3030-3032	e.	_	_	_	_
16-29	3033-3035	g.	_	_	_	_
16-30	3036-3037	,	_	_	_	_
16-31	3038-3041	see	_	_	_	_
16-32	3042-3043	)	_	_	_	_
16-33	3044-3045	.	_	_	_	_

#Text=Limitations
17-1	3046-3057	Limitations	abstract	new	coref	18-12[143_0]

#Text=All these findings should be taken into account in light of some limitations .
18-1	3058-3061	All	abstract[140]	giv[140]	_	_
18-2	3062-3067	these	abstract[140]	giv[140]	_	_
18-3	3068-3076	findings	abstract[140]	giv[140]	_	_
18-4	3077-3083	should	_	_	_	_
18-5	3084-3086	be	_	_	_	_
18-6	3087-3092	taken	_	_	_	_
18-7	3093-3097	into	_	_	_	_
18-8	3098-3105	account	abstract[141]	new[141]	coref	26-7[0_141]
18-9	3106-3108	in	abstract[141]	new[141]	_	_
18-10	3109-3114	light	abstract[141]|object[142]	new[141]|new[142]	_	_
18-11	3115-3117	of	abstract[141]|object[142]	new[141]|new[142]	_	_
18-12	3118-3122	some	abstract[141]|object[142]|abstract[143]	new[141]|new[142]|giv[143]	_	_
18-13	3123-3134	limitations	abstract[141]|object[142]|abstract[143]	new[141]|new[142]|giv[143]	_	_
18-14	3135-3136	.	_	_	_	_

#Text=First , the relatively small sample size does not allow drawing considerations based on subgroups ( e. g. , gender- or age-based , etc. ) .
19-1	3137-3142	First	_	_	_	_
19-2	3143-3144	,	_	_	_	_
19-3	3145-3148	the	quantity[145]	new[145]	_	_
19-4	3149-3159	relatively	quantity[145]	new[145]	_	_
19-5	3160-3165	small	quantity[145]	new[145]	_	_
19-6	3166-3172	sample	object|quantity[145]	new|new[145]	_	_
19-7	3173-3177	size	quantity[145]	new[145]	_	_
19-8	3178-3182	does	_	_	_	_
19-9	3183-3186	not	_	_	_	_
19-10	3187-3192	allow	_	_	_	_
19-11	3193-3200	drawing	abstract[146]	new[146]	coref	30-4[243_146]
19-12	3201-3215	considerations	abstract[146]	new[146]	_	_
19-13	3216-3221	based	_	_	_	_
19-14	3222-3224	on	_	_	_	_
19-15	3225-3234	subgroups	abstract	new	appos	19-17[148_0]
19-16	3235-3236	(	_	_	_	_
19-17	3237-3239	e.	abstract[148]	giv[148]	appos	19-20[0_148]
19-18	3240-3242	g.	abstract[148]	giv[148]	_	_
19-19	3243-3244	,	_	_	_	_
19-20	3245-3252	gender-	abstract	giv	_	_
19-21	3253-3255	or	_	_	_	_
19-22	3256-3265	age-based	_	_	_	_
19-23	3266-3267	,	_	_	_	_
19-24	3268-3272	etc.	_	_	_	_
19-25	3273-3274	)	_	_	_	_
19-26	3275-3276	.	_	_	_	_

#Text=This fact did not allow investigating the possible effects of confounding factors , including gender-specific ones ( i. e. , the sexual-hormone influences for female subjects , menstrual cycle phases , etc. ) or variables related to some physical characteristics of the subjects ( i. e. , the body mass index ) , even though none of the volunteers was apparently under- or overweight .
20-1	3277-3281	This	abstract[150]	new[150]	_	_
20-2	3282-3286	fact	abstract[150]	new[150]	_	_
20-3	3287-3290	did	_	_	_	_
20-4	3291-3294	not	_	_	_	_
20-5	3295-3300	allow	_	_	_	_
20-6	3301-3314	investigating	_	_	_	_
20-7	3315-3318	the	abstract[151]	new[151]	coref	25-16[204_151]
20-8	3319-3327	possible	abstract[151]	new[151]	_	_
20-9	3328-3335	effects	abstract[151]	new[151]	_	_
20-10	3336-3338	of	_	_	_	_
20-11	3339-3350	confounding	_	_	_	_
20-12	3351-3358	factors	abstract[152]	new[152]	_	_
20-13	3359-3360	,	abstract[152]	new[152]	_	_
20-14	3361-3370	including	abstract[152]	new[152]	_	_
20-15	3371-3386	gender-specific	abstract[152]|abstract[153]	new[152]|new[153]	_	_
20-16	3387-3391	ones	abstract[152]|abstract[153]	new[152]|new[153]	_	_
20-17	3392-3393	(	_	_	_	_
20-18	3394-3396	i.	_	_	_	_
20-19	3397-3399	e.	_	_	_	_
20-20	3400-3401	,	_	_	_	_
20-21	3402-3405	the	abstract[154]	new[154]	_	_
20-22	3406-3420	sexual-hormone	abstract[154]	new[154]	_	_
20-23	3421-3431	influences	abstract[154]	new[154]	_	_
20-24	3432-3435	for	abstract[154]	new[154]	_	_
20-25	3436-3442	female	abstract[154]|abstract[155]	new[154]|giv[155]	coref	20-42[161_155]
20-26	3443-3451	subjects	abstract[154]|abstract[155]	new[154]|giv[155]	_	_
20-27	3452-3453	,	abstract[154]	new[154]	_	_
20-28	3454-3463	menstrual	abstract[154]|person|abstract[158]	new[154]|new|new[158]	_	_
20-29	3464-3469	cycle	abstract[154]|abstract|abstract[158]	new[154]|new|new[158]	_	_
20-30	3470-3476	phases	abstract[154]|abstract[158]	new[154]|new[158]	_	_
20-31	3477-3478	,	abstract[154]	new[154]	_	_
20-32	3479-3483	etc.	abstract[154]	new[154]	_	_
20-33	3484-3485	)	_	_	_	_
20-34	3486-3488	or	_	_	_	_
20-35	3489-3498	variables	abstract	new	_	_
20-36	3499-3506	related	_	_	_	_
20-37	3507-3509	to	_	_	_	_
20-38	3510-3514	some	abstract[160]	new[160]	_	_
20-39	3515-3523	physical	abstract[160]	new[160]	_	_
20-40	3524-3539	characteristics	abstract[160]	new[160]	_	_
20-41	3540-3542	of	abstract[160]	new[160]	_	_
20-42	3543-3546	the	abstract[160]|abstract[161]	new[160]|giv[161]	_	_
20-43	3547-3555	subjects	abstract[160]|abstract[161]	new[160]|giv[161]	_	_
20-44	3556-3557	(	_	_	_	_
20-45	3558-3560	i.	_	_	_	_
20-46	3561-3563	e.	_	_	_	_
20-47	3564-3565	,	_	_	_	_
20-48	3566-3569	the	abstract[164]	new[164]	coref	28-21[229_164]
20-49	3570-3574	body	object|abstract[164]	new|new[164]	_	_
20-50	3575-3579	mass	quantity|abstract[164]	new|new[164]	_	_
20-51	3580-3585	index	abstract[164]	new[164]	_	_
20-52	3586-3587	)	_	_	_	_
20-53	3588-3589	,	_	_	_	_
20-54	3590-3594	even	_	_	_	_
20-55	3595-3601	though	_	_	_	_
20-56	3602-3606	none	event	new	_	_
20-57	3607-3609	of	_	_	_	_
20-58	3610-3613	the	person[166]	giv[166]	coref	21-37[175_166]
20-59	3614-3624	volunteers	person[166]	giv[166]	_	_
20-60	3625-3628	was	_	_	_	_
20-61	3629-3639	apparently	_	_	_	_
20-62	3640-3646	under-	_	_	_	_
20-63	3647-3649	or	_	_	_	_
20-64	3650-3660	overweight	_	_	_	_
20-65	3661-3662	.	_	_	_	_

#Text=Second , due to the necessity of keeping the overall length of the protocol reasonably low , we did not consider long-term ANS measurements that could be more precise in characterizing the overall stress state of the volunteers .
21-1	3663-3669	Second	_	_	_	_
21-2	3670-3671	,	_	_	_	_
21-3	3672-3675	due	_	_	_	_
21-4	3676-3678	to	_	_	_	_
21-5	3679-3682	the	abstract[167]	new[167]	_	_
21-6	3683-3692	necessity	abstract[167]	new[167]	_	_
21-7	3693-3695	of	_	_	_	_
21-8	3696-3703	keeping	_	_	_	_
21-9	3704-3707	the	quantity[168]	new[168]	_	_
21-10	3708-3715	overall	quantity[168]	new[168]	_	_
21-11	3716-3722	length	quantity[168]	new[168]	_	_
21-12	3723-3725	of	quantity[168]	new[168]	_	_
21-13	3726-3729	the	quantity[168]|abstract[169]	new[168]|giv[169]	_	_
21-14	3730-3738	protocol	quantity[168]|abstract[169]	new[168]|giv[169]	_	_
21-15	3739-3749	reasonably	quantity[168]|abstract[169]	new[168]|giv[169]	_	_
21-16	3750-3753	low	quantity[168]|abstract[169]	new[168]|giv[169]	_	_
21-17	3754-3755	,	_	_	_	_
21-18	3756-3758	we	person	giv	ana	22-8
21-19	3759-3762	did	_	_	_	_
21-20	3763-3766	not	_	_	_	_
21-21	3767-3775	consider	_	_	_	_
21-22	3776-3785	long-term	abstract[172]	new[172]	_	_
21-23	3786-3789	ANS	place|abstract[172]	giv|new[172]	coref	23-25
21-24	3790-3802	measurements	abstract[172]	new[172]	_	_
21-25	3803-3807	that	_	_	_	_
21-26	3808-3813	could	_	_	_	_
21-27	3814-3816	be	_	_	_	_
21-28	3817-3821	more	_	_	_	_
21-29	3822-3829	precise	_	_	_	_
21-30	3830-3832	in	_	_	_	_
21-31	3833-3847	characterizing	_	_	_	_
21-32	3848-3851	the	abstract[174]	new[174]	coref	22-34[186_174]
21-33	3852-3859	overall	abstract[174]	new[174]	_	_
21-34	3860-3866	stress	abstract|abstract[174]	giv|new[174]	coref	23-15[192_0]
21-35	3867-3872	state	abstract[174]	new[174]	_	_
21-36	3873-3875	of	abstract[174]	new[174]	_	_
21-37	3876-3879	the	abstract[174]|person[175]	new[174]|giv[175]	_	_
21-38	3880-3890	volunteers	abstract[174]|person[175]	new[174]|giv[175]	_	_
21-39	3891-3892	.	_	_	_	_

#Text=Third , for the same reason , we decided not to administer stress-related questionnaires , such as Visual Analogue Scale ( VAS ) or State-Trait Anxiety Inventory ( STAI ) , to monitor both state and trait anxiety .
22-1	3893-3898	Third	_	_	_	_
22-2	3899-3900	,	_	_	_	_
22-3	3901-3904	for	_	_	_	_
22-4	3905-3908	the	abstract[176]	new[176]	coref	24-4[196_176]
22-5	3909-3913	same	abstract[176]	new[176]	_	_
22-6	3914-3920	reason	abstract[176]	new[176]	_	_
22-7	3921-3922	,	_	_	_	_
22-8	3923-3925	we	person	giv	ana	24-9
22-9	3926-3933	decided	_	_	_	_
22-10	3934-3937	not	_	_	_	_
22-11	3938-3940	to	_	_	_	_
22-12	3941-3951	administer	_	_	_	_
22-13	3952-3966	stress-related	abstract[178]	new[178]	_	_
22-14	3967-3981	questionnaires	abstract[178]	new[178]	_	_
22-15	3982-3983	,	abstract[178]	new[178]	_	_
22-16	3984-3988	such	abstract[178]	new[178]	_	_
22-17	3989-3991	as	abstract[178]	new[178]	_	_
22-18	3992-3998	Visual	abstract[178]|abstract[179]|object[180]	new[178]|new[179]|new[180]	appos|appos	22-22[0_180]|22-22[0_180]
22-19	3999-4007	Analogue	abstract[178]|abstract[179]|object[180]	new[178]|new[179]|new[180]	_	_
22-20	4008-4013	Scale	abstract[178]|object[180]	new[178]|new[180]	_	_
22-21	4014-4015	(	_	_	_	_
22-22	4016-4019	VAS	object	giv	_	_
22-23	4020-4021	)	_	_	_	_
22-24	4022-4024	or	_	_	_	_
22-25	4025-4036	State-Trait	animal|abstract[184]	new|new[184]	_	_
22-26	4037-4044	Anxiety	abstract|abstract[184]	new|new[184]	coref	22-37[188_0]
22-27	4045-4054	Inventory	abstract[184]	new[184]	_	_
22-28	4055-4056	(	_	_	_	_
22-29	4057-4061	STAI	object	new	_	_
22-30	4062-4063	)	_	_	_	_
22-31	4064-4065	,	_	_	_	_
22-32	4066-4068	to	_	_	_	_
22-33	4069-4076	monitor	_	_	_	_
22-34	4077-4081	both	abstract[186]	giv[186]	_	_
22-35	4082-4087	state	abstract[186]	giv[186]	_	_
22-36	4088-4091	and	_	_	_	_
22-37	4092-4097	trait	abstract|abstract[188]	new|giv[188]	_	_
22-38	4098-4105	anxiety	abstract[188]	giv[188]	_	_
22-39	4106-4107	.	_	_	_	_

#Text=Such protocols can be applied in future studies , allowing assessing possible correlations between the subjective , perceived stress and the variations of the ANS parameters .
23-1	4108-4112	Such	abstract[189]	giv[189]	coref	30-7[244_189]
23-2	4113-4122	protocols	abstract[189]	giv[189]	_	_
23-3	4123-4126	can	_	_	_	_
23-4	4127-4129	be	_	_	_	_
23-5	4130-4137	applied	_	_	_	_
23-6	4138-4140	in	_	_	_	_
23-7	4141-4147	future	abstract[190]	new[190]	coref	26-11[208_190]
23-8	4148-4155	studies	abstract[190]	new[190]	_	_
23-9	4156-4157	,	_	_	_	_
23-10	4158-4166	allowing	_	_	_	_
23-11	4167-4176	assessing	_	_	_	_
23-12	4177-4185	possible	abstract[191]	giv[191]	_	_
23-13	4186-4198	correlations	abstract[191]	giv[191]	_	_
23-14	4199-4206	between	abstract[191]	giv[191]	_	_
23-15	4207-4210	the	abstract[191]|abstract[192]	giv[191]|giv[192]	_	_
23-16	4211-4221	subjective	abstract[191]|abstract[192]	giv[191]|giv[192]	_	_
23-17	4222-4223	,	abstract[191]|abstract[192]	giv[191]|giv[192]	_	_
23-18	4224-4233	perceived	abstract[191]|abstract[192]	giv[191]|giv[192]	_	_
23-19	4234-4240	stress	abstract[191]|abstract[192]	giv[191]|giv[192]	_	_
23-20	4241-4244	and	abstract[191]	giv[191]	_	_
23-21	4245-4248	the	abstract[191]|abstract[193]	giv[191]|new[193]	coref	27-27[215_193]
23-22	4249-4259	variations	abstract[191]|abstract[193]	giv[191]|new[193]	_	_
23-23	4260-4262	of	abstract[191]|abstract[193]	giv[191]|new[193]	_	_
23-24	4263-4266	the	abstract[191]|abstract[193]|abstract[195]	giv[191]|new[193]|giv[195]	_	_
23-25	4267-4270	ANS	abstract[191]|abstract[193]|place|abstract[195]	giv[191]|new[193]|giv|giv[195]	coref	29-27
23-26	4271-4281	parameters	abstract[191]|abstract[193]|abstract[195]	giv[191]|new[193]|giv[195]	_	_
23-27	4282-4283	.	_	_	_	_

#Text=Fourth , for the reason mentioned above , we decided to keep the recovery phase reasonably short .
24-1	4284-4290	Fourth	_	_	_	_
24-2	4291-4292	,	_	_	_	_
24-3	4293-4296	for	_	_	_	_
24-4	4297-4300	the	abstract[196]	giv[196]	_	_
24-5	4301-4307	reason	abstract[196]	giv[196]	_	_
24-6	4308-4317	mentioned	_	_	_	_
24-7	4318-4323	above	_	_	_	_
24-8	4324-4325	,	_	_	_	_
24-9	4326-4328	we	person	giv	_	_
24-10	4329-4336	decided	_	_	_	_
24-11	4337-4339	to	_	_	_	_
24-12	4340-4344	keep	_	_	_	_
24-13	4345-4348	the	abstract[199]	giv[199]	coref	25-6[201_199]
24-14	4349-4357	recovery	event|abstract[199]	giv|giv[199]	_	_
24-15	4358-4363	phase	abstract[199]	giv[199]	_	_
24-16	4364-4374	reasonably	_	_	_	_
24-17	4375-4380	short	_	_	_	_
24-18	4381-4382	.	_	_	_	_

#Text=With a longer duration of this phase , one could have inferred the duration of the autonomic effects of both cognitive and sensory stimulation .
25-1	4383-4387	With	_	_	_	_
25-2	4388-4389	a	abstract[200]	new[200]	_	_
25-3	4390-4396	longer	abstract[200]	new[200]	_	_
25-4	4397-4405	duration	abstract[200]	new[200]	_	_
25-5	4406-4408	of	abstract[200]	new[200]	_	_
25-6	4409-4413	this	abstract[200]|abstract[201]	new[200]|giv[201]	ana	25-9[0_201]
25-7	4414-4419	phase	abstract[200]|abstract[201]	new[200]|giv[201]	_	_
25-8	4420-4421	,	_	_	_	_
25-9	4422-4425	one	abstract	giv	coref	29-30[240_0]
25-10	4426-4431	could	_	_	_	_
25-11	4432-4436	have	_	_	_	_
25-12	4437-4445	inferred	_	_	_	_
25-13	4446-4449	the	abstract[203]	new[203]	_	_
25-14	4450-4458	duration	abstract[203]	new[203]	_	_
25-15	4459-4461	of	abstract[203]	new[203]	_	_
25-16	4462-4465	the	abstract[203]|abstract[204]	new[203]|giv[204]	_	_
25-17	4466-4475	autonomic	abstract[203]|abstract[204]	new[203]|giv[204]	_	_
25-18	4476-4483	effects	abstract[203]|abstract[204]	new[203]|giv[204]	_	_
25-19	4484-4486	of	abstract[203]|abstract[204]	new[203]|giv[204]	_	_
25-20	4487-4491	both	abstract[203]|abstract[204]|abstract[205]	new[203]|giv[204]|giv[205]	_	_
25-21	4492-4501	cognitive	abstract[203]|abstract[204]|abstract[205]	new[203]|giv[204]|giv[205]	_	_
25-22	4502-4505	and	abstract[203]|abstract[204]|abstract[205]	new[203]|giv[204]|giv[205]	_	_
25-23	4506-4513	sensory	abstract[203]|abstract[204]|abstract[205]	new[203]|giv[204]|giv[205]	_	_
25-24	4514-4525	stimulation	abstract[203]|abstract[204]|abstract[205]	new[203]|giv[204]|giv[205]	_	_
25-25	4526-4527	.	_	_	_	_

#Text=This limitation could be taken into account and solved in future studies .
26-1	4528-4532	This	abstract[206]	new[206]	_	_
26-2	4533-4543	limitation	abstract[206]	new[206]	_	_
26-3	4544-4549	could	_	_	_	_
26-4	4550-4552	be	_	_	_	_
26-5	4553-4558	taken	_	_	_	_
26-6	4559-4563	into	_	_	_	_
26-7	4564-4571	account	abstract	giv	_	_
26-8	4572-4575	and	_	_	_	_
26-9	4576-4582	solved	_	_	_	_
26-10	4583-4585	in	_	_	_	_
26-11	4586-4592	future	abstract[208]	giv[208]	coref	28-1[221_208]
26-12	4593-4600	studies	abstract[208]	giv[208]	_	_
26-13	4601-4602	.	_	_	_	_

#Text=Fifth , the somewhat counterintuitive results retrieved in studying time- versus frequency-domain features were partially explained by the contrasting literature explanation regarding the physiological processes underlying frequency-domain variations , as explained in the signal analysis subsection of the Materials and Methods .
27-1	4603-4608	Fifth	_	_	_	_
27-2	4609-4610	,	_	_	_	_
27-3	4611-4614	the	abstract[209]	giv[209]	_	_
27-4	4615-4623	somewhat	abstract[209]	giv[209]	_	_
27-5	4624-4640	counterintuitive	abstract[209]	giv[209]	_	_
27-6	4641-4648	results	abstract[209]	giv[209]	_	_
27-7	4649-4658	retrieved	_	_	_	_
27-8	4659-4661	in	_	_	_	_
27-9	4662-4670	studying	_	_	_	_
27-10	4671-4676	time-	abstract	new	_	_
27-11	4677-4683	versus	_	_	_	_
27-12	4684-4700	frequency-domain	abstract[211]	giv[211]	coref	28-13[225_211]
27-13	4701-4709	features	abstract[211]	giv[211]	_	_
27-14	4710-4714	were	_	_	_	_
27-15	4715-4724	partially	_	_	_	_
27-16	4725-4734	explained	_	_	_	_
27-17	4735-4737	by	_	_	_	_
27-18	4738-4741	the	abstract[213]	new[213]	_	_
27-19	4742-4753	contrasting	abstract[213]	new[213]	_	_
27-20	4754-4764	literature	abstract|abstract[213]	new|new[213]	_	_
27-21	4765-4776	explanation	abstract[213]	new[213]	_	_
27-22	4777-4786	regarding	_	_	_	_
27-23	4787-4790	the	abstract[214]	new[214]	_	_
27-24	4791-4804	physiological	abstract[214]	new[214]	_	_
27-25	4805-4814	processes	abstract[214]	new[214]	_	_
27-26	4815-4825	underlying	_	_	_	_
27-27	4826-4842	frequency-domain	abstract[215]	giv[215]	_	_
27-28	4843-4853	variations	abstract[215]	giv[215]	_	_
27-29	4854-4855	,	_	_	_	_
27-30	4856-4858	as	_	_	_	_
27-31	4859-4868	explained	_	_	_	_
27-32	4869-4871	in	_	_	_	_
27-33	4872-4875	the	abstract[218]	new[218]	_	_
27-34	4876-4882	signal	abstract|abstract[218]	new|new[218]	_	_
27-35	4883-4891	analysis	abstract|abstract[218]	new|new[218]	_	_
27-36	4892-4902	subsection	abstract[218]	new[218]	_	_
27-37	4903-4905	of	abstract[218]	new[218]	_	_
27-38	4906-4909	the	abstract[218]|substance[219]	new[218]|new[219]	_	_
27-39	4910-4919	Materials	abstract[218]|substance[219]	new[218]|new[219]	_	_
27-40	4920-4923	and	abstract[218]	new[218]	_	_
27-41	4924-4931	Methods	abstract[218]|abstract	new[218]|new	_	_
27-42	4932-4933	.	_	_	_	_

#Text=Further studies conducted on larger samples , and using other time-domains and more robust ECG features , including RMSSD and the Cardiac Vagal Index calculated from the Lorenz plot , could also help in clarifying this point .
28-1	4934-4941	Further	abstract[221]	giv[221]	coref	30-31[250_221]
28-2	4942-4949	studies	abstract[221]	giv[221]	_	_
28-3	4950-4959	conducted	_	_	_	_
28-4	4960-4962	on	_	_	_	_
28-5	4963-4969	larger	object[222]	new[222]	_	_
28-6	4970-4977	samples	object[222]	new[222]	_	_
28-7	4978-4979	,	_	_	_	_
28-8	4980-4983	and	_	_	_	_
28-9	4984-4989	using	_	_	_	_
28-10	4990-4995	other	abstract[223]	new[223]	_	_
28-11	4996-5008	time-domains	abstract[223]	new[223]	_	_
28-12	5009-5012	and	_	_	_	_
28-13	5013-5017	more	abstract[225]	giv[225]	_	_
28-14	5018-5024	robust	abstract[225]	giv[225]	_	_
28-15	5025-5028	ECG	abstract|abstract[225]	new|giv[225]	_	_
28-16	5029-5037	features	abstract[225]	giv[225]	_	_
28-17	5038-5039	,	_	_	_	_
28-18	5040-5049	including	_	_	_	_
28-19	5050-5055	RMSSD	abstract	new	_	_
28-20	5056-5059	and	_	_	_	_
28-21	5060-5063	the	abstract[229]	giv[229]	_	_
28-22	5064-5071	Cardiac	person|abstract[229]	new|giv[229]	_	_
28-23	5072-5077	Vagal	person|abstract[229]	new|giv[229]	_	_
28-24	5078-5083	Index	abstract[229]	giv[229]	_	_
28-25	5084-5094	calculated	_	_	_	_
28-26	5095-5099	from	_	_	_	_
28-27	5100-5103	the	object[231]	new[231]	_	_
28-28	5104-5110	Lorenz	person|object[231]	new|new[231]	_	_
28-29	5111-5115	plot	object[231]	new[231]	_	_
28-30	5116-5117	,	_	_	_	_
28-31	5118-5123	could	_	_	_	_
28-32	5124-5128	also	_	_	_	_
28-33	5129-5133	help	_	_	_	_
28-34	5134-5136	in	_	_	_	_
28-35	5137-5147	clarifying	_	_	_	_
28-36	5148-5152	this	abstract[232]	new[232]	_	_
28-37	5153-5158	point	abstract[232]	new[232]	_	_
28-38	5159-5160	.	_	_	_	_

#Text=Finally , the administration of both pleasant and unpleasant odors would have represented a possible confounding factor if one ’s aim was to control the selective ANS response to one of the two categories .
29-1	5161-5168	Finally	_	_	_	_
29-2	5169-5170	,	_	_	_	_
29-3	5171-5174	the	abstract[233]	new[233]	_	_
29-4	5175-5189	administration	abstract[233]	new[233]	_	_
29-5	5190-5192	of	abstract[233]	new[233]	_	_
29-6	5193-5197	both	abstract[233]|abstract[234]	new[233]|new[234]	coref	30-17[0_234]
29-7	5198-5206	pleasant	abstract[233]|abstract[234]	new[233]|new[234]	_	_
29-8	5207-5210	and	abstract[233]|abstract[234]	new[233]|new[234]	_	_
29-9	5211-5221	unpleasant	abstract[233]|abstract[234]	new[233]|new[234]	_	_
29-10	5222-5227	odors	abstract[233]|abstract[234]	new[233]|new[234]	_	_
29-11	5228-5233	would	_	_	_	_
29-12	5234-5238	have	_	_	_	_
29-13	5239-5250	represented	_	_	_	_
29-14	5251-5252	a	abstract[235]	new[235]	_	_
29-15	5253-5261	possible	abstract[235]	new[235]	_	_
29-16	5262-5273	confounding	abstract[235]	new[235]	_	_
29-17	5274-5280	factor	abstract[235]	new[235]	_	_
29-18	5281-5283	if	_	_	_	_
29-19	5284-5287	one	person[236]|abstract[237]	new[236]|new[237]	_	_
29-20	5288-5290	’s	person[236]|abstract[237]	new[236]|new[237]	_	_
29-21	5291-5294	aim	abstract[237]	new[237]	_	_
29-22	5295-5298	was	_	_	_	_
29-23	5299-5301	to	_	_	_	_
29-24	5302-5309	control	_	_	_	_
29-25	5310-5313	the	abstract[239]	giv[239]	_	_
29-26	5314-5323	selective	abstract[239]	giv[239]	_	_
29-27	5324-5327	ANS	place|abstract[239]	giv|giv[239]	_	_
29-28	5328-5336	response	abstract[239]	giv[239]	_	_
29-29	5337-5339	to	_	_	_	_
29-30	5340-5343	one	abstract[240]	giv[240]	_	_
29-31	5344-5346	of	abstract[240]	giv[240]	_	_
29-32	5347-5350	the	abstract[240]|abstract[241]	giv[240]|new[241]	_	_
29-33	5351-5354	two	abstract[240]|abstract[241]	giv[240]|new[241]	_	_
29-34	5355-5365	categories	abstract[240]|abstract[241]	giv[240]|new[241]	_	_
29-35	5366-5367	.	_	_	_	_

#Text=In light of such considerations , future protocols could be structured starting from the selection of odors based on their hedonic tone , even referring to pleasantness data reported in previously published studies .
30-1	5368-5370	In	_	_	_	_
30-2	5371-5376	light	abstract[242]	new[242]	_	_
30-3	5377-5379	of	abstract[242]	new[242]	_	_
30-4	5380-5384	such	abstract[242]|abstract[243]	new[242]|giv[243]	_	_
30-5	5385-5399	considerations	abstract[242]|abstract[243]	new[242]|giv[243]	_	_
30-6	5400-5401	,	_	_	_	_
30-7	5402-5408	future	abstract[244]	giv[244]	_	_
30-8	5409-5418	protocols	abstract[244]	giv[244]	_	_
30-9	5419-5424	could	_	_	_	_
30-10	5425-5427	be	_	_	_	_
30-11	5428-5438	structured	_	_	_	_
30-12	5439-5447	starting	_	_	_	_
30-13	5448-5452	from	_	_	_	_
30-14	5453-5456	the	abstract[245]	new[245]	_	_
30-15	5457-5466	selection	abstract[245]	new[245]	_	_
30-16	5467-5469	of	abstract[245]	new[245]	_	_
30-17	5470-5475	odors	abstract[245]|abstract	new[245]|giv	ana	30-20
30-18	5476-5481	based	_	_	_	_
30-19	5482-5484	on	_	_	_	_
30-20	5485-5490	their	abstract|abstract[248]	giv|new[248]	_	_
30-21	5491-5498	hedonic	abstract[248]	new[248]	_	_
30-22	5499-5503	tone	abstract[248]	new[248]	_	_
30-23	5504-5505	,	_	_	_	_
30-24	5506-5510	even	_	_	_	_
30-25	5511-5520	referring	_	_	_	_
30-26	5521-5523	to	_	_	_	_
30-27	5524-5536	pleasantness	abstract[249]	new[249]	_	_
30-28	5537-5541	data	abstract[249]	new[249]	_	_
30-29	5542-5550	reported	_	_	_	_
30-30	5551-5553	in	_	_	_	_
30-31	5554-5564	previously	abstract[250]	giv[250]	_	_
30-32	5565-5574	published	abstract[250]	giv[250]	_	_
30-33	5575-5582	studies	abstract[250]	giv[250]	_	_
30-34	5583-5584	.	_	_	_	_
